Skip to main content

Find Clinical Trials

Home
Conditions
Regorafenib

Clinical trial condition

Regorafenib

Explore clinical trials studying Regorafenib. Study availability and eligibility vary by location and protocol.

3 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Regorafenib trial results

Recruiting

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

NCT07071961

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +11 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.

NCT07343791

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
Locations: Jinling Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases

NCT05794971

Conditions: Colorectal Cancer Liver Metastases, Regorafenib
Locations: Bo Zhang Guangdong, Guangzhou, China

View Trial Details